Search result for 'drugs and cosmetics act'

India's Health Ministry grants MSME pharma companies an additional year to meet revised GMP standards under Schedule M, pushing the deadline to December 31, 2025. The decision comes after requests...

India's medical technology industry is expected to reach USD 20 billion in exports by 2030, but needs government support for growth, says CII. The industry body highlights the need for more PLI...

India's drug regulator clarifies on recall of substandard medicines and action against fake drug manufacturers. Learn about the difference between 'not of standard quality' and 'spurious' medicines.

Cochin International Airport Ltd (CIAL) has been authorized by the Union Ministry of Health and Family Welfare for importing medicines and cosmetics, making it one of 11 airports in India with this...

India's DPIIT Secretary highlights relaxed FDI norms in the space sector and potential for further liberalization under the new government, emphasizing the country's commitment to attracting...

A court has issued an interim stay on the suspension of manufacturing licences for 14 Patanjali drugs, following a preliminary inquiry report that found the suspension order to be illegal.

Pharma industry leaders highlight India's rising attractiveness for clinical trials, citing recent reforms and a robust healthcare infrastructure. Learn about the factors driving this trend.